Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting

Background: Peripheral artery disease (PAD) patients undergoing infrainguinal angioplasty with stenting suffer high rates of target lesion restenosis and ischemic events. Blood-based prognostic markers in these patients are currently limited. The IL-33/ST2-system is involved in atherothrombosis. Sol...

Full description

Bibliographic Details
Main Authors: Stefan Stojkovic, Svitlana Demyanets, Christoph W. Kopp, Christian Hengstenberg, Johann Wojta, Beate Eichelberger, Simon Panzer, Thomas Gremmel
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
peripheral artery disease
sST2
ischemic outcomes
platelet reactivity
tissue factor
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2020.605669/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2020.605669/full

Similar Items